Ground News

Understand the Nuance

PharmaVOICE image

News from PharmaVOICE

Your destination for news from PharmaVOICE. See how PharmaVOICE’s media bias impacts the breaking news stories of today.

In total, 71 have been published by PharmaVOICE which Ground News has aggregated in the past 3 months.

The Ground News media bias check for PharmaVOICE is Center. Scores are assigned by aggregating bias scores from Ad Fontes Media, Media Bias/Fact Check, and All Sides.

PharmaVOICE’s aggregated factuality score is High. Factuality is assigned by combining fact check, credibility, and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about PharmaVOICE

Where is PharmaVOICE located?PharmaVOICE's Website

Media Bias Ratings

Average Bias Rating:

Center

Center

byMedia Bias/Fact Check

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top PharmaVOICE News

FDA to offer faster drug reviews to companies promoting ‘national priorities’

FDA · United States

FDA to offer faster drug reviews to companies promoting ‘national priorities’

66% Center coverage: 63 sources

FDA Says It's Investigating Sarepta’s Duchenne Patient Deaths

United States · United States

FDA Says It's Investigating Sarepta’s Duchenne Patient Deaths

91% Center coverage: 11 sources

(MedPage Today) -- The FDA is investigating the deaths of two boys with Duchenne muscular dystrophy who died soon after being treated with delandistrogene moxeparvovec (Elevidys) gene therapy, the agency said. The investigation will focus on the...See the Story

Proposed Crackdown on Pharma Ads Leaves Cable TV Fearing $10B Withdrawal

Bernie Sanders · United States

Proposed Crackdown on Pharma Ads Leaves Cable TV Fearing $10B Withdrawal

Coverage: 4 sources

There’s a big regulatory shift under consideration in Washington. Possible side effects could be lethal for cable TV. On Tuesday, Bloomberg reported that the White House is considering policies that would ban pharmaceutical companies from directly advertising to patients. The news comes just after Senators Bernie Sanders and Angus King introduced a bill with similar intentions last week. If it goes into effect, it could leave a $10 billion void …See the Story

How a Big Pharma veteran looks to stand out in biotech as a unique ‘drug hunter’

100% Center coverage: 1 sources

J&J’s former head of R&D, now CEO of Parabilis Medicines, aims to remain above the biotech fray by taking on unique targets from which others have steered clear.Pharma · United States Read Article

Biogen scores Cannes Festival win with dark humored campaign

100% Center coverage: 1 sources

The company’s unique campaign for a rare, terminal illness nabbed millions of views and a spot on the main stage at the Cannes Lions Festival of Creativity.Cannes Film Festival · Cannes Read Article

Megablockbusters are the holy grail. Here’s how drugmakers are getting there.

100% Center coverage: 1 sources

More drugs surpassed $10 billion in revenue last year than ever before.Read Article

Biotech’s Turning Point: for Every Challenge, an Opportunity in Disguise

100% Center coverage: 1 sources

As hurdles litter biotech’s future, forward-thinking leaders look for ways to leap to the other side.Biotech · United States See the Story

How a patient group tackled research diversity for one disease and triggered change for pharma

100% Center coverage: 1 sources

A policy win by the Foundation for Sarcoidosis Research has built momentum for other shifts that could bolster diversity in clinical trials.Read Article

Locked in a federal stalemate, states take PBM reform into their own hands

100% Center coverage: 1 sources

Arkansas is leading the nation in banning PBMs from owning pharmacies, as other states advance new restrictions.Little Rock · Little Rock Read Article

How integrated data systems enhance clinical development and manufacturing

100% Center coverage: 1 sources

How CDMOs are adapting to the surge in demand by committing to digital transformation.Read Article

Will Pharma Finally Score a Policy Win for 340B?

100% Center coverage: 1 sources

The industry is awaiting guidance on a rebate approach to the contentious drug discount program for hospitals and aiming for tighter oversight.CVS · United States See the Story

Breaking News Topics Related to PharmaVOICE